Skip to main content
Clinical Trials/NCT00785031
NCT00785031
Completed
Not Applicable

Internet-based Vascular Risk Factor Management for Patients With Clinical Manifest Vascular Disease; a Randomized Controlled Trial

UMC Utrecht2 sites in 1 country330 target enrollmentOctober 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
UMC Utrecht
Enrollment
330
Locations
2
Primary Endpoint
Framingham heart risk score
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The objective of the study is to evaluate the efficacy and cost-effectiveness of an internet based vascular risk factor program on top of usual care compared to usual care alone for treatment of vascular risk factors in patients at high risk for new vascular events.

Detailed Description

The objective of the study is to evaluate the efficacy and cost-effectiveness of an internet based vascular risk factor program on top of usual care compared to usual care alone for treatment of vascular risk factors in patients at high risk for new vascular events. Study design: randomized non-blinded trial Study population: patients in the Rijnstate Hospital Arnhem and the UMC Utrecht, The Netherlands with a recent diagnosis of cerebral, cardiac or peripheral artery disease that entered the risk factor screening programs in these hospitals revealing 2 or more treatable risk factors. Intervention: After the screening program patients will be randomized to usual care alone or to the internet program on top of usual care. Usual care for risk factor management will be delivered by the medical specialist and/or the general practitioner. Patients randomized to the internet based intervention program are first seen by the nurse practitioner on a regular clinic visit. The internet dossier is than created and explained to the patient. Subsequent contacts between nurse practitioner and patient about risk factor management is mainly by the internet. The nurse practitioner works according to the national guidelines for cardiovascular risk management ('CardioVascular Risico Management 2006') and is supervised by an internist. The study period is 1 year. All patients in both groups ware asked to return to the clinic for a follow up measurement of risk factors after 1 year. Outcome measures: Primary outcome is the difference in Framingham heart risk score between baseline and after 1 year. As secondary outcome the percentage of patients achieving treatment goals for each risk factor and the average change in the absolute value of each risk factors after 1 year will be used. Sample size calculation/data analysis: 380 patients. Changes in risk factors (absolute change and fraction of patients achieving treatment goal of each risk factor) at the start and after 1 year and between the groups are tested with independent sample t-test and Chi-square test. Economic evaluation: The balance between costs and effects of the internet based vascular risk factor management program will be compared to usual care. Using a previously developed cardiovascular disease model incremental cost-utility analyses will be conducted with remaining life expectancy as the relevant time horizon.

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
June 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

dr.Frank L.J. Visseren

Prof.

UMC Utrecht

Eligibility Criteria

Inclusion Criteria

  • Participation in a cardiovascular risk screening program
  • 2 or more modifiable risk factors not on target:
  • SBP \> 140 mmHg
  • LDL-c \> 2.5 mmol/l
  • Triglycerides \> 1.7 mmol/l
  • BMI \> 25 kg/m2
  • Diabetes Mellitus or fasting glucose \> 6.1 mmol/l

Exclusion Criteria

  • No internet access at home
  • Unable to read and write Dutch
  • Dependent in in daily activities (Ranking score \>=3)
  • Life expectancy \< 2 years or an active malignant disease

Outcomes

Primary Outcomes

Framingham heart risk score

Time Frame: 1 year

Secondary Outcomes

  • Percentage of patients achieving treatment goals for each risk factor(1 year)
  • Additional costs per additional patient achieving treatment goal(1 year)
  • Cost per life year gained, cost per QALY(1 year)

Study Sites (2)

Loading locations...

Similar Trials